P-87 TRANSCULTURAL ADAPTATION OF THE MEDITERRANEAN DIET TO THE DIETARY HABITS OF EACH GEOGRAPHICAL REGION OF ARGENTINA FOR THE TREATMENT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOT... by Maria Adela Crosetti, Alejandra Maynat, Andrea Zúñiga

Get full text

Low-Intensity Pulsed Ultrasound Enhanced Adipose-Derived Stem Cell-Mediated Angiogenesis in the Treatment of Diabetic Erectile Dysfunction through the Piezo-ERK-VEGF Axis by Shiyun Liu, Chenyi Jiang, Jianlin Hu, Huixing Chen, Bangmin Han, Shujie Xia

“…Objectives. Erectile dysfunction is a major comorbidity of diabetes. Stem cell transplantation is a promising method to treat diabetic erectile dysfunction. …”
Get full text

Comprehensive Assessment of Cardiohemodynamics and Catestatin Parameters as a Possible Predictor of Cardiovascular Dysfunction in Patients with Arterial Hypertension without and wi... by І. Dunaieva

“…Arterial hypertension (AH), type 2 diabetes mellitus (T2DM), and obesity form a cardiometabolic continuum with a high risk of cardiovascular dysfunction. Catestatin (CST) is a promising biomarker of neurohumoral activation and may reflect early cardiac functional abnormalities, especially diastolic dysfunction.       …”
Get full text

Prevalence of Erectile Dysfunction and Associated Factors among Hypertensive Patients Attending Governmental Health Institutions in Gondar City, Northwest Ethiopia: A Cross-Section... by Deribew Abebaw Abuhay, Yibeltal Yismaw Gela, Ayechew Adera Getu

“…Introduction. Erectile dysfunction is a common sexual problem affecting men with hypertension. …”
Get full text

Hepatokine leukocyte cell‐derived chemotaxin 2 as a biomarker of insulin resistance, liver enzymes, and metabolic dysfunction‐associated steatotic liver disease in the general popu... by Keita Suzuki, Hiromasa Tsujiguchi, Akinori Hara, Yumie Takeshita, Hisanori Goto, Yujiro Nakano, Reina Yamamoto, Hiroaki Takayama, Atsushi Tajima, Tatsuya Yamashita, Masao Honda, Hiroyuki Nakamura, Toshinari Takamura

“…Since LECT2 is up‐regulated by the inactivation of the energy sensor AMPK in the liver, we hypothesized that LECT2 has potential as a biomarker for metabolic dysfunction‐associated steatotic liver disease (MASLD). …”
Get full text

Poliumoside inhibits apoptosis, oxidative stress and neuro-inflammation to prevent intracerebroventricular streptozotocin-induced cognitive dysfunction in Sprague–Dawley rats: an i... by Yanan Zuo, Bineng Chen, Xiaokun Li, Guocheng Liu

“…MATERIALS AND METHODS: Initially, cognitive dysfunction in rats was induced by the intracerebroventricular administration of streptozotocin. …”
Get full text

Myocardial cytoprotectors demonstrate anti-apoptotic effect on vascular endotheliocytes by A. I. Inzhutova

“…Trimetazidine MR could be used as pathogenetic therapy, correcting vascular wall homeostasis in CVD patients, and also as prevention of endothelial dysfunction progression in NCD patients.…”
Get full text

Risk factors for kidney damage in COVID-19 patients admitted to the intensive care unit by Diana K. Sarkisian, Natalia V. Chebotareva, Valerie McDonnell, Armen V. Oganesyan, Tatyana N. Krasnova, Egor A. Makarov

Get full text

Moexipril in postmenopausal women with arterial hypertension by M. G. Glezer, E. B. Tkhostova, M. A. Demidova, Yu. B. Belousov

Get full text

The phenomenon of déjà vu in focal epilepsy, literature review by M. Yu. Kissin, T. M. Goguadze, Yu. A. Yakovleva

Get full text

Endothelial function and vascular reactivity in workplace hypertension by I. V. Osipova, O. N. Antropova, N. O. Glebov, G. A. Beloshapkina, T. V. Perevozchikova, N. M. Legkoshkurova

Get full text

Endothelial function and lipid peroxidation in patients with arterial hypertension and its cerebral complications by M. V. Kazak, T. S. Romanenko, M. G. Omelyanenko, A. V. Lebedeva, I. K. Tomilova, V. N. Vyatkin, A. V. Kontsevaya

“…UncomplicatedAH was characterised by compensated endothelial dysfunction, while NO-endothelium system was decompensated in stroke. …”
Get full text

Diastolic stress test in assessing functional state of postinfarction myocardium by A. M. Vorobev, V. I. Ruzov

“…Myocardial infarction is accompanied by the presence of LV diastolic dysfunction in 53,5 % of the patients at the 6th week of the rehabilitation period. …”
Get full text

Prognostic value of renal function in patients with acute decompensation of chronic heart failure by I. A. Meray, A. Yu. Yurovsky, E. P. Pavlikova, M. A. Efremovtseva, V. S. Moiseev

“…In this group, 13 (10,8%) patients died - substantially more than in participants without progressing renal dysfunction (19 (7%) deaths).Conclusion. In patients hospitalized with AD CHF, baseline GFR decrease was observed in 69%, including 20% with severe renal dysfunction (GFR<30 ml/min/1,73 m2). …”
Get full text

Target organs in patients with post-infarction chronic heart failure: dynamics during complex therapy including beta-adrenoblockers by I. P. Rubesh, L. A. Nekrutenko, A. V. Tuev, Yu. V. Larina, A. V. Agafonov

Get full text

EFFECTIVENESS OF ROSUVASTATIN IN VERY HIGH RISK CARDIOVASCULAR PATIENTS IN THE ACTUAL OUTPATIENT PRACTICE by V. P. Mikhin, D. V. Nebieridze, N. M. Akhmedzhanov, Yu. A. Zhilyaeva

“…To evaluate the comparative efficacy of Rosivastatin (Rosart) and atorvastatin in patients with very high grade of cardiovascular risk (CVR), arterial hypertension (AH) and chronic ischemic heart disease (CHD) in outpatient practice.Material and methods. Totally, 2 groups studied, of patients with chronic CHD with AH (n=50) and isolated AH (n=50) with very high CVR by SCORE, had taken during 1 year the traditional antianginal, antihypertension therapy, and aspirin. …”
Get full text

Long-term consequences of COVID-19 on sleep, mental health, fatigue, and cognition: a preliminary study by Armin Adibi, Ali Motahharynia, Iman Adibi, Mehdi Sanayei

“…Material and methods Between April and December 2021, 45 COVID-19 individuals and 60 healthy individuals met the eligibility criteria. …”
Get full text

Renal function in patients with anemia and severe chronic heart failure: effects of iron medications by M. A. Efremovtseva, T. A. Kasantseva, L. G. Aleksandriya, T. B. Dmitrova

“…To investigate the prevalence of anemia and renal dysfunction combination among patients with severe chronic heart failure (CHF), as well as the effects of intravenous (i/v) iron therapy.Material and methods. …”
Get full text

EFFECT OF SIMVASTATIN THERAPY ON INDICATORS OF TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE by T. V. Pinchuk, Y. N. Fedulaev, G. A. Khairetdinova, A. A. Kozina, V. N. Ryzhenkov, N. M. Ahmedzhanov

“…On the basis of EchoCG data diastolic dysfunction types were determined in patients of the main group. …”
Get full text

EFFECT OF SIMVASTATIN ON THE PROGNOSIS AND THE CHANGES OF THE CLINICAL STATUS IN PATIENTS WITH ACUTE ISCHEMIC STROKE. THE RESULTS OF THE 12 MONTH RANDOMIZED, OPEN COMPARATIVE STUD... by V. V. Yakusevich, A. Yu. Malygin, A. V. Kabanov

Get full text